Alts
- STARTUPSSTARTUPS · 1 min
Biotech Startup Cellogen Therapeutics Raises ₹20 Cr from Kotak Alts
Cellogen Therapeutics has closed a ₹20 crore Series A round led by Kotak Alternate Asset Managers, the biotech startup disclosed on 12 June according to in…
18 May, 05:31 pm IST - FUNDING · BIOTECHFUNDING · BIOTECH · 3 min
Kotak Alts pumps ₹20 Cr into Cellogen Therapeutics for India cell-therapy push
₹20 Cr round will fund preclinical studies and IP build-out; Kotak Alts eyes India’s $10 Bn biotech opportunity
18 May, 04:34 pm IST